Transparency is here for meetings and events. The Physician Payments Sunshine Act, though collection starts in 2012, and reporting is not required until 2013. is quickly becoming top of mind at pharmaceutical and biotech firms everywhere. While no one argues that transparency in an industry is "bad", many in the industry are challenged by the implementation of such far reaching legislation. Couple that with the learning curve and technology requirements of reporting and many companies are, quite frankly, scrambling. [Read more...]